Display options
Share it on

Front Endocrinol (Lausanne). 2016 Mar 02;7:19. doi: 10.3389/fendo.2016.00019. eCollection 2016.

Browning and Graying: Novel Transcriptional Regulators of Brown and Beige Fat Tissues and Aging.

Frontiers in endocrinology

Elisabetta Mueller

Affiliations

  1. Genetics of Development and Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health , Bethesda, MD , USA.

PMID: 26973598 PMCID: PMC4773441 DOI: 10.3389/fendo.2016.00019

Abstract

Obesity represents a major risk factor for the development of a number of metabolic disorders, including cardiovascular disease and type 2 diabetes. Since the discovery that brown and beige fat cells exist in adult humans and contribute to energy expenditure, increasing interest has been devoted to the understanding of the molecular switches turning on calorie utilization. It has been reported that the ability of thermogenic tissues to burn energy declines during aging, possibly contributing to the development of metabolic dysfunction late in life. This review will focus on the recently identified transcriptional modulators of brown and beige cells and will discuss the potential impact of some of these thermogenic factors on age-associated metabolic disorders.

Keywords: FoxA3; HSF1; age-associated metabolic dysfunction; brown fat thermogenesis; transcription factors

References

  1. Cell. 2015 May 21;161(5):999-1011 - PubMed
  2. Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):143-9 - PubMed
  3. Proc Natl Acad Sci U S A. 2012 Jun 12;109 (24):9635-40 - PubMed
  4. Cell Metab. 2011 Mar 2;13(3):249-59 - PubMed
  5. Cell Metab. 2014 May 6;19(5):810-20 - PubMed
  6. Cell. 2014 Jul 3;158(1):69-83 - PubMed
  7. Cell. 2015 Oct 22;163(3):643-55 - PubMed
  8. N Engl J Med. 2009 Apr 9;360(15):1500-8 - PubMed
  9. Cell Metab. 2014 Apr 1;19(4):593-604 - PubMed
  10. Genes Dev. 2015 Feb 1;29(3):298-307 - PubMed
  11. Stem Cells. 2014 May;32(5):1323-36 - PubMed
  12. N Engl J Med. 2009 Apr 9;360(15):1509-17 - PubMed
  13. Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14289-94 - PubMed
  14. Genes Dev. 2012 Feb 1;26(3):271-81 - PubMed
  15. Genes Dev. 2008 May 15;22(10):1269-75 - PubMed
  16. Cell Mol Life Sci. 2006 Oct;63(19-20):2317-28 - PubMed
  17. Cell Metab. 2013 May 7;17 (5):798-805 - PubMed
  18. Cell. 2012 Jul 20;150(2):366-76 - PubMed
  19. Genes Dev. 2015 Jan 1;29(1):7-22 - PubMed
  20. Nature. 2008 Aug 21;454(7207):961-7 - PubMed
  21. Diabetes. 2012 Jun;61(6):1315-22 - PubMed
  22. J Clin Invest. 2011 Jan;121(1):96-105 - PubMed
  23. Biochim Biophys Acta. 2014 Mar;1842(3):352-7 - PubMed
  24. Mol Cell. 2015 Jan 22;57(2):235-46 - PubMed
  25. Cell Metab. 2006 Oct;4(4):263-73 - PubMed
  26. Cell. 1998 Mar 20;92(6):829-39 - PubMed
  27. J Clin Endocrinol Metab. 2010 Jan;95(1):256-62 - PubMed
  28. Dev Cell. 2013 Aug 26;26(4):393-404 - PubMed
  29. Nutr Diabetes. 2012 Sep 17;2:e46 - PubMed
  30. Mol Cell Biol. 2013 Sep;33(17):3392-9 - PubMed
  31. Endocr Rev. 2003 Feb;24(1):78-90 - PubMed
  32. Cell. 2014 Jan 16;156(1-2):304-16 - PubMed
  33. Nat Neurosci. 1998 May;1(1):69-73 - PubMed
  34. Curr Opin Clin Nutr Metab Care. 2011 Jan;14(1):1-6 - PubMed
  35. Cell. 2012 Aug 31;150(5):948-60 - PubMed
  36. Elife. 2014 May 29;3:null - PubMed
  37. Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20376-81 - PubMed
  38. Cell. 2010 Oct 1;143(1):156-69 - PubMed
  39. Front Endocrinol (Lausanne). 2012 Feb 06;3:14 - PubMed
  40. Cell Metab. 2005 Nov;2(5):283-95 - PubMed
  41. Cell. 1999 Jul 9;98 (1):115-24 - PubMed
  42. Cell Metab. 2015 Oct 6;22(4):695-708 - PubMed
  43. Cell Metab. 2007 Jul;6(1):38-54 - PubMed
  44. N Engl J Med. 2009 Apr 9;360(15):1518-25 - PubMed
  45. Genes Dev. 2013 Feb 1;27(3):234-50 - PubMed
  46. Cell Metab. 2010 Apr 7;11(4):268-72 - PubMed
  47. Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1085-105 - PubMed

Publication Types